Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis

被引:25
|
作者
Wu, Xinle [1 ]
Li, Yang [1 ]
机构
[1] Amgen Inc, 1120 Vet Blvd, San Francisco, CA 94080 USA
来源
AGING-US | 2009年 / 1卷 / 12期
关键词
fibroblast growth factors; FGF19; FGF21; FGF23; aging; diabetes; metabolic diseases; insulin; METABOLIC-ACTIVITY; BETA-KLOTHO; GROWTH; SPECIFICITY; SUPPRESSION; DETERMINES; EXPRESSION; SIGNAL; FAMILY; MODE;
D O I
10.18632/aging.100108
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FGF19, FGF21, and FGF23 form a unique subfamily of fibroblast growth factors. Because they contain intra molecular disulfide bonds and show reduced affinity toward heparan sulfate located in the extracellular space, it is thought that, in contrast to other FGFs, they function as endocrine hormones. FGF23 and its co-receptor alpha Klotho are involved in the control of aging, but it is not known if the same holds true for FGF19, which can also signal through alpha Klotho. However, considerable evidence supports a role for FGF19 in controlling various aspects of metabolism. We have recently fully characterized FGF19/FGFR/co-factor interactions and signaling, and in the current manuscript discuss the contribution of the FGF19/FGFR4 axis to bile acid and glucose regulation.
引用
收藏
页码:1023 / 1027
页数:5
相关论文
共 50 条
  • [21] Characterisation of FGF19, FGF21, and FGF23 stimulated FGFR1/4 activation
    Sommerfeld, M.
    Klein, K.
    Kleinmann, C.
    Kleinschmidt, K.
    Risch, S.
    Boscheinen, O.
    Schaefer, H. -L.
    DIABETOLOGIA, 2010, 53
  • [22] FGF19/FGFR4信号通路在肝细胞癌中的研究进展
    王磊
    陈欣菊
    现代肿瘤医学, 2019, 27 (16) : 2949 - 2954
  • [23] The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
    Kanzaki, Hiroaki
    Chiba, Tetsuhiro
    Ao, Junjie
    Koroki, Keisuke
    Kanayama, Kengo
    Maruta, Susumu
    Maeda, Takahiro
    Kusakabe, Yuko
    Kobayashi, Kazufumi
    Kanogawa, Naoya
    Kiyono, Soichiro
    Nakamura, Masato
    Kondo, Takayuki
    Saito, Tomoko
    Nakagawa, Ryo
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Ooka, Yoshihiko
    Muroyama, Ryosuke
    Nakamoto, Shingo
    Yasui, Shin
    Tawada, Akinobu
    Arai, Makoto
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Mimura, Naoya
    Kato, Jun
    Zen, Yoh
    Ohtsuka, Masayuki
    Iwama, Atsushi
    Kato, Naoya
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
    Hiroaki Kanzaki
    Tetsuhiro Chiba
    Junjie Ao
    Keisuke Koroki
    Kengo Kanayama
    Susumu Maruta
    Takahiro Maeda
    Yuko Kusakabe
    Kazufumi Kobayashi
    Naoya Kanogawa
    Soichiro Kiyono
    Masato Nakamura
    Takayuki Kondo
    Tomoko Saito
    Ryo Nakagawa
    Sadahisa Ogasawara
    Eiichiro Suzuki
    Yoshihiko Ooka
    Ryosuke Muroyama
    Shingo Nakamoto
    Shin Yasui
    Akinobu Tawada
    Makoto Arai
    Tatsuo Kanda
    Hitoshi Maruyama
    Naoya Mimura
    Jun Kato
    Yoh Zen
    Masayuki Ohtsuka
    Atsushi Iwama
    Naoya Kato
    Scientific Reports, 11
  • [25] FGF19 sustains the high proliferative ability of keratinocytes in psoriasis through the regulation of Wnt/GSK-3β/β-catenin signalling via FGFR4
    Yu, Xiaoyun
    Yan, Ning
    Li, Zihai
    Hua, Yunhui
    Chen, Wei
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (08) : 761 - 769
  • [26] Characterization of a FGF19 Variant with Altered Receptor Specificity Revealed a Central Role for FGFR1c in the Regulation of Glucose Metabolism
    Ge, Hongfei
    Baribault, Helene
    Vonderfecht, Steven
    Lemon, Bryan
    Weiszmann, Jennifer
    Gardner, Jonitha
    Lee, Ki Jeong
    Gupte, Jamila
    Mookherjee, Paramita
    Wang, Minghan
    Sheng, Jackie
    Wu, Xinle
    Li, Yang
    PLOS ONE, 2012, 7 (03):
  • [27] Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival
    Tiong, Kai Hung
    Tan, Boon Shing
    Choo, Heng Lungh
    Chung, Felicia Fei-Lei
    Hii, Ling-Wei
    Tan, Si Hoey
    Khor, Nelson Tze Woei
    Wong, Shew Fung
    See, Sze-Jia
    Tan, Yuen-Fen
    Rosli, Rozita
    Cheong, Soon-Keng
    Leong, Chee-Onn
    ONCOTARGET, 2016, 7 (36) : 57633 - 57650
  • [28] FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β-catenin signaling cascade via FGFR4 activation
    Zhao, Huakan
    Lv, Fenglin
    Liang, Guizhao
    Huang, Xiaobin
    Wu, Gang
    Zhang, Wenfa
    Yu, Le
    Shi, Lei
    Teng, Yong
    ONCOTARGET, 2016, 7 (12) : 13575 - 13586
  • [29] Regulation of renal phosphate transport by FGF23 is mediated by FGFR1 and FGFR4
    Gattineni, Jyothsna
    Alphonse, Priyatharshini
    Zhang, Qiuyu
    Mathews, Nisha
    Bates, Carlton M.
    Baum, Michel
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 306 (03) : F351 - F358
  • [30] 原发性胆汁性肝硬化患者血清FGF19、Klotho及FGFR4蛋白表达的意义
    张振
    干敏芝
    中国基层医药, 2022, 29 (05) : 660 - 663